comparemela.com

Latest Breaking News On - Corevalve evolut - Page 4 : comparemela.com

Medtronic touts 3-year data for Evolut TAVR

Medtronic (NYSE:MDT) announced three-year data supporting its Evolut transcatheter aortic valve replacement (TAVR) system.

John forrestCorevalve evolutMedtronic evolutNina goodheartWorld heart federation congressYale school of medicineJournal of the american college cardiologyAmerican college of cardiologyEvolut low riskAmerican collegeAnnual scientific session togetherWorld heart federationWorld congressYale schoolEvolut low risk trialStructural heart

At 5 Years, TAVI Valves Perform Better Than Surgical Ones

TAVR valves deteriorate less than surgical valves at 5 years in patients treated for severe aortic stenosis.

United statesMichaelj reardonGregoryp fontanaStevenj yakubovCorevalve evolutLos robles health systemEuropean association of percutaneous cardiovascular interventionsBoston scientificCardiovascular research technologiesMedstar heart vascular instituteOhiohealth research institute at riverside methodist hospitalP valve academic research consortiumMedstar heartEuropean associationPercutaneous cardiovascular interventionsOhiohealth research institute

New Durability Definitions Still Give Self-Expanding TAVI an Edge vs SAVR

The study has implications for surgical practice as well as TAVI, especially as it expands to younger patients, experts say.

New yorkUnited statesHoward herrmannSteven yakubovMichael reardonCorevalve evolutDavid cohenEdwards lifesciencesGregory fontanaHospital corporation of americaOhio healthMd cardiovascular instituteMd hospital of the university pennsylvaniaRiverside methodistGregg stoneIcahn school

Data backs durability of Medtronic CoreValve Evolut TAVR

Medtronic today announced five-year data that supports its CoreValve Evolut transcatheter aortic valve replacement (TAVR) implant.

Riverside methodist hospitalUnited statesSteven yakubovCorevalve evolutMedtronic corevalve evolutNina goodheartCardiovascular research technologiesOhio healthValve evolutStructural heart

Medtronic hit with $106 5M verdict in CoreValve TAVI patent case

Medtronic must pay $106.5 million in a TAVI patent infringement lawsuit, a federal jury in California ruled this week.

United statesCorevalve evolutMedtronic corevalveJoseph hornColibri heart valveCorevalve evolut proValve evolutEdwards lifescienceCentral californiaStar tribune

vimarsana © 2020. All Rights Reserved.